Showing results (1201-1210 of 6,501) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|May 5, 2019
Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profileDaniëlle Krijgsman, Natasja L de Vries, Anni Skovbo, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1987
Augmentation of the generation of cell-mediated cytotoxicity in culture by mitomycin CT Akiyoshi, S Arinaga, H TsujiCancer Immunology, Immunotherapy : CII|January 1, 1987
A phase I study of recombinant interferon gamma administered by s.c. injection three times per week in patients with solid tumoursJ Wagstaff, D Smith, P Nelmes, et al.Cancer Immunology, Immunotherapy : CII|August 20, 2018
Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanismTing Chen, Qing Li, Jiao Wu, et al.Cancer Immunology, Immunotherapy : CII|August 22, 2018
IL-10 inducible CD8+ regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cellsJulian Plaumann, Melanie Engelhardt, Mohamed H S Awwad, et al.Cancer Immunology, Immunotherapy : CII|August 23, 2018
Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicityFrank Neumann, Fabian Acker, Claudia Schormann, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1986
Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery. Correlation with the postsurgical clinical courseF Vánky, E Klein, J Willems, et al.Cancer Immunology, Immunotherapy : CII|September 24, 2021
Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinomaMichael W Knitz, Laurel B Darragh, Thomas E Bickett, et al.Cancer Immunology, Immunotherapy : CII|September 27, 2021
Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experienceSeoyoung Lee, Hyo Sup Shim, Beung-Chul Ahn, et al.Cancer Immunology, Immunotherapy : CII|October 18, 2021
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefitEmily Nickles, Bhushan Dharmadhikari, Li Yating, et al.Pageof 651